SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-16-006879
Filing Date
2016-08-17
Accepted
2016-08-17 16:11:40
Documents
3
Period of Report
2016-08-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vtgn8k_aug162016.htm 8-K 25600
2 RESTATED ARTICLES OF INCORPORATION OF VISTAGEN THERAPEUTICS, INC., DATED AUGUST ex3-1.htm EX-3.1 39375
3 SECOND AMENDED AND RESTATED BYLAWS OF VISTAGEN THERAPEUTICS, INC., DATED AUGUST ex3-2.htm EX-3.2 145753
  Complete submission text file 0001415889-16-006879.txt   211974
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 161838704
SIC: 2834 Pharmaceutical Preparations